U.S. Opioid Epidemic: Supply-Side Causes and Policy Solutions
This executive summary examines the U.S. opioid epidemic through a supply-side lens, drawing primarily on research by Pacula and Powell (2018) published through RAND. It covers the historical background of the crisis, including the pharmaceutical industry's role in flooding the market with cheap, highly addictive prescription drugs and government incentives that encouraged overprescription. The summary presents key economic indicators — including a Council of Economic Advisors estimate placing the cost of opioid fatalities at $431.7 billion in 2017 — and outlines the shift from prescription opioids to illicit street drugs such as heroin and fentanyl. Three policy recommendations are proposed: reducing the black-market supply of opioids, treating addiction as a mental health issue rather than a criminal one, and expanding access to medication-assisted treatment (MAT).
- Introduction: Purpose and scope of the executive summary
- Background of the Opioid Epidemic: Pharmaceutical origins and societal harms of the crisis
- Key Research Findings: Supply-side drivers identified by Pacula and Powell
- Economic Indicators of the Crisis: Hundreds of billions in costs to economy and healthcare
- Policy Recommendations: Three strategies to reduce supply and support addicts
- Conclusion: Summary of findings and recommended policy actions
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Grounds policy recommendations directly in peer-reviewed and government research, giving the argument an evidence-based foundation that strengthens credibility.
- Uses concrete economic figures — such as the $431.7 billion cost of opioid fatalities — to illustrate the fiscal stakes of inaction, making the crisis tangible for a policy audience.
- Balances supply-side analysis with demand-side solutions (treatment, mental health framing), showing awareness of the crisis's complexity without losing analytical focus.
Key academic technique demonstrated
The paper demonstrates effective use of executive summary structure: it synthesizes multiple sources (Pacula & Powell 2018, HHS, Council of Economic Advisors) into a coherent narrative and translates research findings into actionable policy recommendations. The use of bulleted findings directly attributed to the source study is a strong technique for distinguishing original research from editorial commentary.
Structure breakdown
The paper follows a standard executive summary format: an opening statement of purpose, a background section contextualizing the crisis, a research-findings section reporting Pacula and Powell's (2018) results and models, an economic indicators section quantifying the fiscal impact, three discrete and labeled policy recommendations, and a synthesizing conclusion. This clear scaffolding makes the argument easy to follow and the recommendations easy to locate.
Introduction
The purpose of this executive summary is to provide an overview of the opioid epidemic in the U.S. and how supply-side factors have played a role in its spread. According to Pacula and Powell (2018), the opioid crisis "is a complex, multifaceted, and dynamic problem requiring a comprehensive strategy for dealing not just with the stock of addicted users who are at risk of overdosing, but also considering the flow of new initiates and escalators in abuse." This summary discusses the background of the issue, the results of Pacula and Powell's (2018) research, available federal data, appropriate economic indicators, and three reliable and implementable policy recommendations.
Background of the Opioid Epidemic
The opioid epidemic has ravaged the United States in recent years. The U.S. Department of Health and Human Services reports that in 2016 alone, 116 people died every day from opioid-related overdoses (HHS, 2018). The problem stems from the rise of the pharmaceutical industry and its development, manufacturing, and sale of prescription drugs that were highly addictive yet very effective at relieving pain. For those who became addicted, these drugs offered a "high" that became desirable in its own right.
This allure has drawn millions of people into illegal use of prescription drugs or abuse of their own prescriptions in pursuit of that effect. The result has been a tremendous loss of life, increased crime, family deterioration, and significant economic harm, as growing numbers of people addicted to opioids are no longer entering the workforce to support their families, communities, and the broader national economy (Blackstone, Fuhr, & Pociask, 2014).
Key Research Findings
The central finding of Pacula and Powell (2018) is that supply-side factors contributed significantly to the rise of the opioid crisis. Pharmaceutical companies bear considerable responsibility, as they manufactured highly addictive drugs and sold them at very low prices, oversaturating the market and making opioids readily available to the public. The federal government also played a role by subsidizing healthcare that included prescription drug treatment, thereby incentivizing physicians to overprescribe in some cases. Pacula and Powell (2018) identify the following specific findings:
Another key finding is that while deaths from prescription opioids have declined since 2010, deaths from illicit opioids such as heroin and fentanyl have increased dramatically. The researchers also identified three major challenges associated with this shift to street drugs:
This means that individuals both selling and using drugs on the street are often unaware of the pharmacological impact of these substances or how to use them in any way that mitigates risk. Rapid misuse can cause severe harm to individuals and their surrounding communities.
Conclusion
The opioid crisis is a serious epidemic in the United States, and Pacula and Powell (2018) have demonstrated that supply-side factors have played a considerable role in its rise. With the pharmaceutical industry manufacturing cheap drugs and healthcare providers incentivized by government reimbursement structures to overprescribe, opioids flooded the market and contributed to a surge in addictions. Illicit opioids are now widely available on the black market, and the economic impact of this crisis is substantial — currently estimated at roughly half a trillion dollars. To counter this crisis, it is recommended that the black-market supply be reduced through law enforcement, that addicts be treated as mental health patients rather than criminals, and that high-quality treatment including MAT be made widely available.
References
Blackstone, E. A., Fuhr, J. P., Jr., & Pociask, S. (2014). The health and economic effects of counterfeit drugs. American Health & Drug Benefits, 7(4), 216.
Council of Economic Advisors. (2017). The underestimated cost of the opioid crisis. Retrieved from
HHS. (2018). About the U.S. opioid epidemic. Retrieved from https://www.hhs.gov/opioids/about-the-epidemic/
Pacula, R., & Powell, D. (2018). A supply-side perspective on the opioid crisis. Retrieved from https://www.rand.org/pubs/external_publications/EP67511.html
Create your account
Always verify citation format against your institution’s current style guide requirements.